Table 1. Summary of bortezomib clinical... | American Society of Hematology

Table 1.

Summary of bortezomib clinical activity in 14 patients with relapsed classical Hodgkin lymphoma

Patient no.	Age, y	Sex	No. of prior treatment regimens	Prior stem cell transplantation	No. of bortezomib cycles received	Best response to bortezomib therapy
1	68	Male	4	Yes	3	Progression
2	47	Male	6	Yes	3	Progression
3	42	Male	5	Yes	3	Progression
4	39	Female	9	Yes	6	PR
5	37	Female	2	Yes	2	Progression
6	32	Female	2	Yes	3	Progression
7	31	Male	5	Yes	6	MR
8	30	Female	7	Yes	6	MR
9	28	Male	3	Yes	1	Progression
10	28	Male	2	Yes	3	Progression
11	25	Female	2	Yes	3	Progression
12	23	Male	2	No	2	Progression
13	21	Male	5	Yes	1	Progression
14	21	Male	3	Yes	3	Progression

Patient no.	Age, y	Sex	No. of prior treatment regimens	Prior stem cell transplantation	No. of bortezomib cycles received	Best response to bortezomib therapy
1	68	Male	4	Yes	3	Progression
2	47	Male	6	Yes	3	Progression
3	42	Male	5	Yes	3	Progression
4	39	Female	9	Yes	6	PR
5	37	Female	2	Yes	2	Progression
6	32	Female	2	Yes	3	Progression
7	31	Male	5	Yes	6	MR
8	30	Female	7	Yes	6	MR
9	28	Male	3	Yes	1	Progression
10	28	Male	2	Yes	3	Progression
11	25	Female	2	Yes	3	Progression
12	23	Male	2	No	2	Progression
13	21	Male	5	Yes	1	Progression
14	21	Male	3	Yes	3	Progression

All patients were refractory to last therapy.

PR indicates partial response; MR, minor response.